COMMUNIQUÉS West-GlobeNewswire

-
Allergy Therapeutics plc - Trading Update and Successful Litigation Settlement
27/06/2019 -
Medtronic Completes Acquisition of Titan Spine
27/06/2019 -
Driven Deliveries Inc. Partners with 10 Brands for Driven’s Brand to Consumer Cannabis Delivery Service
27/06/2019 -
New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS System for the Treatment of Patients with Obsessive Compulsive Disorder
27/06/2019 -
Aleafia Health Announces Closing of $40.25 Million Public Offering, Including Full Exercise of the Over-Allotment Option
27/06/2019 -
Chembio Diagnostics Receives CE Mark for its Point-of-Care Multiplex Test for Zika, Dengue and Chikungunya
27/06/2019 -
INmune Bio Announces Publication of Data on INKmune Primed NK cells in Peer-Reviewed Journal PLOS ONE
27/06/2019 -
Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc.
27/06/2019 -
Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Markets Related Activities
27/06/2019 -
Chicago-based Psychiatrist, Dr. Fabian Carbonell, Debuts Innovative FDA-Cleared Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
27/06/2019 -
Kannalife, Inc. to Present Breakthrough CIPN Study Findings on the Comparison of KLS-13019 to CBD at 29th Annual International Cannabinoid Research Society Conference
27/06/2019 -
Alphatec Announces Organizational and Corporate Updates
27/06/2019 -
OLAH Healthcare Technology welcomes Max Immelman as Senior Sales Executive
27/06/2019 -
RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing
27/06/2019 -
Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
27/06/2019 -
Spring Bank to Present Pre-Clinical Data on Its Novel STING Antagonist Program at The Autoimmunity Conference
27/06/2019 -
Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA
27/06/2019 -
Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
27/06/2019 -
REPEAT - AgraFlora Organics Provides Licensing Guidance and Operational Updates at GMP-Certified GTA Bottling Facility
27/06/2019
Pages